Mehdi M.
- Country
- Hungary
- Department
- Bőr-, Nemikórtani és Onkodermatológiai Klinika
Research Overview
- Efficacy and Safety Evaluation of JNJ-77242113 Versus Placebo and Deucravacitinib in Moderate to Severe Plaque Psoriasis: A Phase 3 Randomized Controlled Trial
- Efficacy and Safety Evaluation of JNJ-77242113 in Moderate to Severe Plaque Psoriasis: A Phase 3 Randomized, Double-blind, Placebo-controlled Study
- Efficacy and Safety Evaluation of JNJ-77242113 in Moderate to Severe Plaque Psoriasis Affecting Special Areas: A Phase 3 Randomized, Double-blind, Placebo-controlled Study
Data & Insights
Has run more than one trial at 72 of 242 partner sites.
Specializations
Dermatological Research
Specialized in investigating therapeutic approaches for plaque psoriasis, with particular emphasis on treatments for varying disease severities ranging from moderate to severe manifestations.
- Moderate to Severe Plaque Psoriasis Management
- Special Areas Psoriasis Treatment
- Novel Therapeutic Interventions
Focuses on evaluating innovative treatment modalities for patients with dermatological conditions affecting both widespread and specific body areas.
Clinical Innovation
Conducts research in advanced therapeutic development with expertise in examining novel compounds for dermatological applications.
- Treatment Efficacy Assessment
- Safety Profile Evaluation
- Long-term Treatment Outcomes
Investigates treatment patterns including withdrawal and retreatment protocols to optimize therapeutic strategies.
Specialized Treatment Areas
Expert in targeted therapeutic approaches for distinct manifestations of psoriasis, particularly focusing on special area involvement.
- Body Surface Area Assessment
- Location-Specific Treatment
- Severity-Based Interventions
Develops specialized treatment protocols for patients with varying presentations of plaque psoriasis.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.